Rebecca Taub

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rebecca Taub:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 656K $287M $437.17 11 Aug 2025 By SQN LLC
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 461K $166M $359.71 12 Aug 2025 Direct
MADRIGAL PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 0 12 Aug 2025 Direct

Insider Reports Filed by Rebecca Taub

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MDGL MADRIGAL PHARMACEUTICALS, INC. 11 Aug 2025 16 -$16.1M 4 Director 13 Aug 2025, 17:33
MDGL MADRIGAL PHARMACEUTICALS, INC. 18 Jul 2025 3 -$341K 4 Director 22 Jul 2025, 17:08
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jul 2025 13 -$10M 4 Director 18 Jul 2025, 16:11
MDGL MADRIGAL PHARMACEUTICALS, INC. 05 Mar 2025 2 $0 4 Pres., R&D, and CMO, Director 07 Mar 2025, 17:00
MDGL MADRIGAL PHARMACEUTICALS, INC. 24 Jan 2025 1 -$217K 4 Pres., R&D, and CMO, Director 27 Jan 2025, 17:07
MDGL MADRIGAL PHARMACEUTICALS, INC. 17 Jan 2025 1 -$462K 4 Pres., R&D, and CMO, Director 17 Jan 2025, 19:05
MDGL MADRIGAL PHARMACEUTICALS, INC. 08 Apr 2024 8 -$633K 4 Pres., R&D, and CMO, Director 10 Apr 2024, 20:53
MDGL MADRIGAL PHARMACEUTICALS, INC. 03 Apr 2024 25 -$17.3M 4 Pres., R&D, and CMO, Director 05 Apr 2024, 20:50
MDGL MADRIGAL PHARMACEUTICALS, INC. 23 Jan 2024 3 $0 4 Pres., R&D, and CMO, Director 25 Jan 2024, 17:54
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jan 2024 1 -$377K 4 Pres., R&D, and CMO, Director 18 Jan 2024, 13:46
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jan 2023 1 $0 4 Pres., R&D, and CMO, Director 18 Jan 2023, 19:00
BCTX BriaCell Therapeutics Corp. 01 Aug 2022 0 $0 3 Director 01 Aug 2022, 16:10
MDGL MADRIGAL PHARMACEUTICALS, INC. 22 Feb 2022 1 $0 4 Chief Medical Officer, President, R&D ** As attorney-in-fact for Reporting Person, Director 24 Feb 2022, 19:12